Kathy Giusti
Encyclopedia
Kathy Giusti is the Founder and Chief Executive Officer of the Multiple Myeloma Research Foundation
(MMRF) and the Multiple Myeloma Research Consortium
(MMRC). In 1998, following her diagnosis with multiple myeloma, Giusti founded the MMRF to fund innovative myeloma research and drug discovery. Having raised more than $120 million to date, the MMRF is the world's number one funder of myeloma research. As an extension of the MMRF's mission, Giusti founded the MMRC in 2004 to enable leading research institutions to work with industry to speed the discovery and development of effective new treatments. Comprising 15 academic institutions across North America, the MMRC is widely recognized for breaking down barriers in tissue banking, data management, genomics, and clinical trials, and is considered an optimal research model to accelerate the development of new therapies. To date, the MMRC has advanced 19 clinical trials of novel compounds and combination approaches through its clinical trials network.
Giusti received her MBA in general management from Harvard Business School and graduated from the University of Vermont magna cum laude with a Bachelor of Science in Biological Sciences. She began her career in 1980 with Merck & Co., and later joined the Gillette Company. In 1993, she joined G.D. Searle & Co., where she last served as Executive Director of Searle's worldwide arthritis franchise.
Giusti has received several awards for her efforts to acdvance medical research and accelerate drug development, including the Centennial Medal for Distinguished Public Service from the American Association for Cancer Research, the Partners in Progress Award from the American Society of Clinical Oncology, the Healthcare Businesswomen's Association's Woman of the Year Award
, and Harvard Business School Entrepreneurial Award. Her efforts have also been recognized by several notable media outlets, including The Wall Street Journal, The New York Times, The New Yorker, Forbes, The Economist, Time, CNBC, CBS Evening News, and NBC Nightly News. She was named to the Time 100
in 2011.
Giusti has served on numerous boards, including the Institute of Medicine's National Cancer Policy Board and the Cancer Leadership Council. Today, she continues to serve on the National Cancer Advisory Board, an appointment she received in 2003 from President Bush, and is a member of the Board of Directors for IMS Health.
Giusti lives in Connecticut with her husband, Paul, and her children, Nicole and David.
Multiple Myeloma Research Foundation
The Multiple Myeloma Research Foundation is a charitable organization dedicated to multiple myeloma, an incurable but treatable blood cancer, which afflicts over fifty thousand Americans alone...
(MMRF) and the Multiple Myeloma Research Consortium
Multiple Myeloma Research Consortium
-About the Multiple Myeloma Research Consortium:The mission of the Multiple Myeloma Research Consortium is to champion collaboration with and integration across academia and industry and to focus on speed and innovation to bring the most promising multiple myeloma treatments to patients faster...
(MMRC). In 1998, following her diagnosis with multiple myeloma, Giusti founded the MMRF to fund innovative myeloma research and drug discovery. Having raised more than $120 million to date, the MMRF is the world's number one funder of myeloma research. As an extension of the MMRF's mission, Giusti founded the MMRC in 2004 to enable leading research institutions to work with industry to speed the discovery and development of effective new treatments. Comprising 15 academic institutions across North America, the MMRC is widely recognized for breaking down barriers in tissue banking, data management, genomics, and clinical trials, and is considered an optimal research model to accelerate the development of new therapies. To date, the MMRC has advanced 19 clinical trials of novel compounds and combination approaches through its clinical trials network.
Giusti received her MBA in general management from Harvard Business School and graduated from the University of Vermont magna cum laude with a Bachelor of Science in Biological Sciences. She began her career in 1980 with Merck & Co., and later joined the Gillette Company. In 1993, she joined G.D. Searle & Co., where she last served as Executive Director of Searle's worldwide arthritis franchise.
Giusti has received several awards for her efforts to acdvance medical research and accelerate drug development, including the Centennial Medal for Distinguished Public Service from the American Association for Cancer Research, the Partners in Progress Award from the American Society of Clinical Oncology, the Healthcare Businesswomen's Association's Woman of the Year Award
Healthcare Businesswomen's Association
The Healthcare Businesswomen's Association was founded in 1977 as a global non-profit organization dedicated to furthering the advancement of women in healthcare worldwide.-Mission:To further the advancement and impact of women in healthcare worldwide...
, and Harvard Business School Entrepreneurial Award. Her efforts have also been recognized by several notable media outlets, including The Wall Street Journal, The New York Times, The New Yorker, Forbes, The Economist, Time, CNBC, CBS Evening News, and NBC Nightly News. She was named to the Time 100
Time 100
Time 100 is an annual list of the 100 most influential people in the world, as assembled by Time. First published in 1999 as a result of a debate among several academics, the list has become an annual event.-History and format:...
in 2011.
Giusti has served on numerous boards, including the Institute of Medicine's National Cancer Policy Board and the Cancer Leadership Council. Today, she continues to serve on the National Cancer Advisory Board, an appointment she received in 2003 from President Bush, and is a member of the Board of Directors for IMS Health.
Giusti lives in Connecticut with her husband, Paul, and her children, Nicole and David.
External links
- The Battle Over New Cancer Drugs from CBS Evening News with Katie Couric
- Life Triumphant from The New Canaan Observer
- Patient Power from Forbes
- Buying A Cure: What Business Know-How Can Do for Disease from The New Yorker
- A Fight to the End from CNN Money
- Time 100 Bio